TrialThe New England journal of medicine2021
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
Nicoletta Colombo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
582 papers cite itlatest 60 shown
this paperpooled ittrialcites it